Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We Need a Dividend Announcement

I like the way your thinking but it would be difficult in my view to buy back 200M shares at .20 or less. I certainly hope that the PPS dosn't stay at the .15 to .20 level for 2 more years. If PTSC announces they will distribute the MMP revenue via dividends to shareholders the PPS should go up substantially. I would think from then on any license announcements would make the PPS rise the way we would expect on good news.

All the best,

Steve

Share
New Message
Please login to post a reply